Sponsorship & Exhibition

Brand recognition

Showcase your company prominently among industry leaders, gaining unparalleled visibility and recognition within the biotechnology community.

Sponsorship opportunities

Tailor your involvement to suit your brand's unique goals, ensuring a bespoke experience that maximizes your reach and strengthens industry relationships.

Participation in the conference

Engage in dynamic discussions, knowledge-sharing sessions, and networking events, ensuring an active role in shaping industry dialogue.

International cooperation

Forge global partnerships and explore collaborative ventures that transcend borders, leveraging this platform to foster cross-cultural exchanges and drive advancements in biotechnology on a global scale.

Place on the website

Enjoy dedicated visibility on our website, ensuring your brand receives prominent exposure to our engaged audience.

Individualized presence

Stand out among other participants, showcasing your specialized contributions and engaging directly with your target audience for personalized interactions.

Registration system for Sponsors and Exhibitors

To participate in the event’s exhibition, please complete the registration process using the links below.

If you already have an Exhibitor account from the previous EUROBIOTECH Congress, please log in to the Exhibitor's system:

LOG IN to the Exhibitor's System

If you have never registered before to the Congress Exhibition, follow the steps to create a new account:

REGISTRATION FOR the NEW EXHIBITORS & PARTNERS

Sponsorship and Exhibition Offer - PDF

Sponsorship and Exhibition Offer Euobiotech 2026.png [1.20 MB]

 

Silver Sponsor

 

cercell.png [149.25 KB]

CerCell® designs, manufactures, and supplies adaptable rigid plastic single-use solutions for upstream bioprocessing applications. Serving the pharmaceutical and life science industries, CerCell supports cultivation, fermentation, and mixing through:

  • Single-Use-Bioreactors (SUBs) for batch and fed-batch processes – CellVessel™
    • Single-Use-Fermenters (SUFs) for microbial applications – BactoVessel®
    • Single-Use-Mixers (SUMs) – CellMiscelatore™

All our products are fully configurable and available in low minimum order quantities, including customized solutions from a single unit for selected product sizes.

 

LPP.png [56.98 KB]

LPP Equipment Warsaw is part of the Swiss LPP Group, operating in 10 Eastern European countries. For more than 20 years, we have served as a vital link between equipment manufacturers and end users, providing solutions for laboratory, pilot-scale, and industrial applications.

Our product portfolio includes:

We provide our customers with technical support throughout the entire lifecycle of the supplied equipment, including:

  • Pre-sales Consulting
  • Installation
  • SAT/IQ/OQ Certification
  • Warranty and Post-Warranty Service

Contact us:

Phone: +48 22 723 00 96
E-mail: info.pl@lpp-equipment.pl
Website: www.lpp-equipment.pl

Bronze Sponsor

Endress+Hauser 1.png [44.50 KB]

Endress+Hauser is a global leader in measurement instrumentation for a wide range of industries, offering a comprehensive portfolio covering virtually all types of measurements.

The Swiss Group employs 18,300 people in 125 countries worldwide. In Poland, it has been a trusted partner for over 30 years, supporting both leading corporations and SMEs by helping Polish companies and production plants in their digital transformation, process optimization, and reduction of environmental impact.

More information: www.pl.endress.com

 

Adamed.png [52.80 KB]

Adamed Pharma is a family-owned pharmaceutical and biotechnology company with 100% Polish capital, built on Polish scientific expertise and proprietary patents. Its portfolio includes nearly 900 products (SKUs). Each year, the company manufactures around 4.5 billion tablets for patients in dozens of markets worldwide. Adamed currently employs almost 3,000 people in Poland and abroad. For 25 years, it has conducted its own innovative R&D, investing PLN 2.6 billion since 2001. In 2025, Adamed Pharma launched Phase I clinical trials for two novel anticancer molecules. The company actively collaborates with leading universities, medical experts and research institutes. Its intellectual property is protected by 277 patents worldwide.

1.png [3.04 MB]

4.png [1.57 MB]

2.png [2.84 MB]

3.png [2.43 MB]